Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of EUR 257.01 billion. The enterprise value is 287.85 billion.

Market Cap	257.01B
Enterprise Value	287.85B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Dec 12, 2025

Share Statistics

Current Share Class	2.47B
Shares Outstanding	n/a
Shares Change (YoY)	-1.34%
Shares Change (QoQ)	-0.40%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	79.98%
Float	2.47B

Valuation Ratios

The trailing PE ratio is 16.53 and the forward PE ratio is 23.63.

PE Ratio	16.53
Forward PE	23.63
PS Ratio	4.64
PB Ratio	5.73
P/TBV Ratio	69.43
P/FCF Ratio	24.41
P/OCF Ratio	18.32
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.39, with an EV/FCF ratio of 27.34.

EV / Earnings	18.52
EV / Sales	5.17
EV / EBITDA	11.39
EV / EBIT	13.74
EV / FCF	27.34

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.96.

Current Ratio	1.54
Quick Ratio	0.96
Debt / Equity	0.96
Debt / EBITDA	1.71
Debt / FCF	4.09
Interest Coverage	18.03

Financial Efficiency

Return on equity (ROE) is 36.88% and return on invested capital (ROIC) is 25.91%.

Return on Equity (ROE)	36.88%
Return on Assets (ROA)	12.04%
Return on Invested Capital (ROIC)	25.91%
Return on Capital Employed (ROCE)	22.54%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	748,241
Profits Per Employee	210,094
Employee Count	74,000
Asset Turnover	0.51
Inventory Turnover	2.32

Taxes

In the past 12 months, Merck & Co. has paid 2.39 billion in taxes.

Income Tax	2.39B
Effective Tax Rate	13.31%

Stock Price Statistics

The stock price has increased by +19.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+19.22%
50-Day Moving Average	95.74
200-Day Moving Average	78.93
Relative Strength Index (RSI)	62.24
Average Volume (20 Days)	242

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.10

Income Statement

In the last 12 months, Merck & Co. had revenue of EUR 55.37 billion and earned 15.55 billion in profits. Earnings per share was 6.20.

Revenue	55.37B
Gross Profit	42.75B
Operating Income	20.84B
Pretax Income	17.94B
Net Income	15.55B
EBITDA	24.79B
EBIT	20.84B
Earnings Per Share (EPS)	6.20

Full Income Statement

Balance Sheet

The company has 12.41 billion in cash and 43.04 billion in debt, giving a net cash position of -30.63 billion.

Cash & Cash Equivalents	12.41B
Total Debt	43.04B
Net Cash	-30.63B
Net Cash Per Share	n/a
Equity (Book Value)	44.85B
Book Value Per Share	18.11
Working Capital	12.94B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.03 billion and capital expenditures -3.50 billion, giving a free cash flow of 10.53 billion.

Operating Cash Flow	14.03B
Capital Expenditures	-3.50B
Free Cash Flow	10.53B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.21%, with operating and profit margins of 37.64% and 28.08%.

Gross Margin	77.21%
Operating Margin	37.64%
Pretax Margin	32.41%
Profit Margin	28.08%
EBITDA Margin	44.77%
EBIT Margin	37.64%
FCF Margin	19.01%

Dividends & Yields

This stock pays an annual dividend of 2.16, which amounts to a dividend yield of 2.07%.

Dividend Per Share	2.16
Dividend Yield	2.07%
Dividend Growth (YoY)	-25.28%
Years of Dividend Growth	n/a
Payout Ratio	44.79%
Buyback Yield	1.34%
Shareholder Yield	3.41%
Earnings Yield	6.05%
FCF Yield	4.10%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 3.5 and a Piotroski F-Score of 5.

Altman Z-Score	3.5
Piotroski F-Score	5